| Electrostim Medical Services Inc | |
| 3504 Cragmont Dr, Ste 100, Tampa, Florida 33619 | |
| (800) 588-8383 |
| Name | Electrostim Medical Services Inc |
|---|---|
| Organization Name | Electrostim Medical Services, Inc. |
| Location | 3504 Cragmont Dr, Ste 100, Tampa, Florida 33619 |
| Type | Durable Medical Equipment & Medical Supplies Supplier |
| Phone | (800) 588-8383 |
| Participate in Medicare | Medicare enrolled and may accept medicare assignment. Please check with the supplier if they accept medicare-approved amount before you get your prescription drugs, equipment or supplies from this supplier. |
News Archive
Nurses, just like many of their patients, struggle to find time and motivation to exercise. But a new study may give these all-important caregivers some additional pressure and responsibility: nurses' attitudes can influence whether their patients commit to a healthy lifestyle.
Verastem, Inc., a biopharmaceutical company focused on discovering and developing drugs to treat breast and other cancers by targeting cancer stem cells, announced today that it has raised $32 million through a Series B financing. Proceeds from the financing will support ongoing research and development and will progress drug candidates into clinical development. The first candidate is projected to enter the clinic in 2012.
Three out of five Israeli clinicians report using placebos – inactive treatments or drugs – in treating patients, despite the medical profession's official disapproval of their use, say the authors of a BMJ Online First paper this week.
The Medicines Company announced today that it has received European approval for the use of Angiox® (bivalirudin) as an anticoagulant in patients with heart attacks (so-called ST-segment elevation myocardial infarction (STEMI)) undergoing emergency heart procedures called primary percutaneous coronary intervention (PCI).
› Verified 7 days ago
| NPI Number | 1073811477 |
| Organization Name | ELECTROSTIM MEDICAL SERVICES, INC. |
| Doing Business As | EMSI |
| Type | Durable Medical Equipment & Medical Supplies Supplier |
| Address | 5425 Oberlin Dr Ste 202, San Diego, CA 92121 |
| Phone Number | 800-588-8383 |
News Archive
Nurses, just like many of their patients, struggle to find time and motivation to exercise. But a new study may give these all-important caregivers some additional pressure and responsibility: nurses' attitudes can influence whether their patients commit to a healthy lifestyle.
Verastem, Inc., a biopharmaceutical company focused on discovering and developing drugs to treat breast and other cancers by targeting cancer stem cells, announced today that it has raised $32 million through a Series B financing. Proceeds from the financing will support ongoing research and development and will progress drug candidates into clinical development. The first candidate is projected to enter the clinic in 2012.
Three out of five Israeli clinicians report using placebos – inactive treatments or drugs – in treating patients, despite the medical profession's official disapproval of their use, say the authors of a BMJ Online First paper this week.
The Medicines Company announced today that it has received European approval for the use of Angiox® (bivalirudin) as an anticoagulant in patients with heart attacks (so-called ST-segment elevation myocardial infarction (STEMI)) undergoing emergency heart procedures called primary percutaneous coronary intervention (PCI).
› Verified 7 days ago
| NPI Number | 1073953535 |
| Organization Name | ELECTROSTIM MEDICAL SERVICES, INC. |
| Doing Business As | EMSI |
| Type | Durable Medical Equipment & Medical Supplies Supplier |
| Address | 3801 Woodland Heights Rd, Suite 125e, Little Rock, AR 72212 |
| Phone Number | 800-588-8383 |
News Archive
Nurses, just like many of their patients, struggle to find time and motivation to exercise. But a new study may give these all-important caregivers some additional pressure and responsibility: nurses' attitudes can influence whether their patients commit to a healthy lifestyle.
Verastem, Inc., a biopharmaceutical company focused on discovering and developing drugs to treat breast and other cancers by targeting cancer stem cells, announced today that it has raised $32 million through a Series B financing. Proceeds from the financing will support ongoing research and development and will progress drug candidates into clinical development. The first candidate is projected to enter the clinic in 2012.
Three out of five Israeli clinicians report using placebos – inactive treatments or drugs – in treating patients, despite the medical profession's official disapproval of their use, say the authors of a BMJ Online First paper this week.
The Medicines Company announced today that it has received European approval for the use of Angiox® (bivalirudin) as an anticoagulant in patients with heart attacks (so-called ST-segment elevation myocardial infarction (STEMI)) undergoing emergency heart procedures called primary percutaneous coronary intervention (PCI).
› Verified 7 days ago
| NPI Number | 1255652442 |
| Organization Name | ELECTROSTIM MEDICAL SERVICES, INC |
| Doing Business As | EMSI |
| Type | Durable Medical Equipment & Medical Supplies Supplier |
| Address | 2148 Embassy Dr, Suite 106, Lancaster, PA 17603 |
| Phone Number | 800-588-8383 |
News Archive
Nurses, just like many of their patients, struggle to find time and motivation to exercise. But a new study may give these all-important caregivers some additional pressure and responsibility: nurses' attitudes can influence whether their patients commit to a healthy lifestyle.
Verastem, Inc., a biopharmaceutical company focused on discovering and developing drugs to treat breast and other cancers by targeting cancer stem cells, announced today that it has raised $32 million through a Series B financing. Proceeds from the financing will support ongoing research and development and will progress drug candidates into clinical development. The first candidate is projected to enter the clinic in 2012.
Three out of five Israeli clinicians report using placebos – inactive treatments or drugs – in treating patients, despite the medical profession's official disapproval of their use, say the authors of a BMJ Online First paper this week.
The Medicines Company announced today that it has received European approval for the use of Angiox® (bivalirudin) as an anticoagulant in patients with heart attacks (so-called ST-segment elevation myocardial infarction (STEMI)) undergoing emergency heart procedures called primary percutaneous coronary intervention (PCI).
› Verified 7 days ago
| NPI Number | 1376809731 |
| Organization Name | ELECTROSTIM MEDICAL SERVICES, INC. |
| Doing Business As | EMSI |
| Type | Durable Medical Equipment & Medical Supplies Supplier |
| Address | 171 Associate Ln, Suite C 5, Indian Trail, NC 28079 |
| Phone Number | 800-588-8383 |
News Archive
Nurses, just like many of their patients, struggle to find time and motivation to exercise. But a new study may give these all-important caregivers some additional pressure and responsibility: nurses' attitudes can influence whether their patients commit to a healthy lifestyle.
Verastem, Inc., a biopharmaceutical company focused on discovering and developing drugs to treat breast and other cancers by targeting cancer stem cells, announced today that it has raised $32 million through a Series B financing. Proceeds from the financing will support ongoing research and development and will progress drug candidates into clinical development. The first candidate is projected to enter the clinic in 2012.
Three out of five Israeli clinicians report using placebos – inactive treatments or drugs – in treating patients, despite the medical profession's official disapproval of their use, say the authors of a BMJ Online First paper this week.
The Medicines Company announced today that it has received European approval for the use of Angiox® (bivalirudin) as an anticoagulant in patients with heart attacks (so-called ST-segment elevation myocardial infarction (STEMI)) undergoing emergency heart procedures called primary percutaneous coronary intervention (PCI).
› Verified 7 days ago
| NPI Number | 1447712518 |
| Organization Name | ELECTROSTIM MEDICAL SERVICES, INC. |
| Doing Business As | EMSI |
| Type | Durable Medical Equipment & Medical Supplies Supplier |
| Address | 9278 Storage Way, Louisville, KY 40291 |
| Phone Number | 800-588-8383 |
News Archive
Nurses, just like many of their patients, struggle to find time and motivation to exercise. But a new study may give these all-important caregivers some additional pressure and responsibility: nurses' attitudes can influence whether their patients commit to a healthy lifestyle.
Verastem, Inc., a biopharmaceutical company focused on discovering and developing drugs to treat breast and other cancers by targeting cancer stem cells, announced today that it has raised $32 million through a Series B financing. Proceeds from the financing will support ongoing research and development and will progress drug candidates into clinical development. The first candidate is projected to enter the clinic in 2012.
Three out of five Israeli clinicians report using placebos – inactive treatments or drugs – in treating patients, despite the medical profession's official disapproval of their use, say the authors of a BMJ Online First paper this week.
The Medicines Company announced today that it has received European approval for the use of Angiox® (bivalirudin) as an anticoagulant in patients with heart attacks (so-called ST-segment elevation myocardial infarction (STEMI)) undergoing emergency heart procedures called primary percutaneous coronary intervention (PCI).
› Verified 7 days ago
| NPI Number | 1518285121 |
| Organization Name | ELECTROSTIM MEDICAL SERVICES INC. |
| Doing Business As | EMSI |
| Type | Durable Medical Equipment & Medical Supplies Supplier |
| Address | 4640 S Carrollton Ave, Suite 200-159, New Orleans, LA 70119 |
| Phone Number | 800-588-8383 |
News Archive
Nurses, just like many of their patients, struggle to find time and motivation to exercise. But a new study may give these all-important caregivers some additional pressure and responsibility: nurses' attitudes can influence whether their patients commit to a healthy lifestyle.
Verastem, Inc., a biopharmaceutical company focused on discovering and developing drugs to treat breast and other cancers by targeting cancer stem cells, announced today that it has raised $32 million through a Series B financing. Proceeds from the financing will support ongoing research and development and will progress drug candidates into clinical development. The first candidate is projected to enter the clinic in 2012.
Three out of five Israeli clinicians report using placebos – inactive treatments or drugs – in treating patients, despite the medical profession's official disapproval of their use, say the authors of a BMJ Online First paper this week.
The Medicines Company announced today that it has received European approval for the use of Angiox® (bivalirudin) as an anticoagulant in patients with heart attacks (so-called ST-segment elevation myocardial infarction (STEMI)) undergoing emergency heart procedures called primary percutaneous coronary intervention (PCI).
› Verified 7 days ago
| NPI Number | 1578881702 |
| Organization Name | ELECTROSTIM MEDICAL SERVICES, INC |
| Doing Business As | EMSI |
| Type | Durable Medical Equipment & Medical Supplies Supplier |
| Address | 9786a Timber Cir Ofc E, Spanish Fort, AL 36527 |
| Phone Number | 800-588-8383 |
News Archive
Nurses, just like many of their patients, struggle to find time and motivation to exercise. But a new study may give these all-important caregivers some additional pressure and responsibility: nurses' attitudes can influence whether their patients commit to a healthy lifestyle.
Verastem, Inc., a biopharmaceutical company focused on discovering and developing drugs to treat breast and other cancers by targeting cancer stem cells, announced today that it has raised $32 million through a Series B financing. Proceeds from the financing will support ongoing research and development and will progress drug candidates into clinical development. The first candidate is projected to enter the clinic in 2012.
Three out of five Israeli clinicians report using placebos – inactive treatments or drugs – in treating patients, despite the medical profession's official disapproval of their use, say the authors of a BMJ Online First paper this week.
The Medicines Company announced today that it has received European approval for the use of Angiox® (bivalirudin) as an anticoagulant in patients with heart attacks (so-called ST-segment elevation myocardial infarction (STEMI)) undergoing emergency heart procedures called primary percutaneous coronary intervention (PCI).
› Verified 7 days ago
| NPI Number | 1629167028 |
| Organization Name | ELECTROSTIM MEDICAL SERVICES INC |
| Doing Business As | EMSI |
| Type | Durable Medical Equipment & Medical Supplies Supplier |
| Address | 3504 Cragmont Dr, Suite # 100, Tampa, FL 33619 |
| Phone Number | 813-931-2369 |
News Archive
Nurses, just like many of their patients, struggle to find time and motivation to exercise. But a new study may give these all-important caregivers some additional pressure and responsibility: nurses' attitudes can influence whether their patients commit to a healthy lifestyle.
Verastem, Inc., a biopharmaceutical company focused on discovering and developing drugs to treat breast and other cancers by targeting cancer stem cells, announced today that it has raised $32 million through a Series B financing. Proceeds from the financing will support ongoing research and development and will progress drug candidates into clinical development. The first candidate is projected to enter the clinic in 2012.
Three out of five Israeli clinicians report using placebos – inactive treatments or drugs – in treating patients, despite the medical profession's official disapproval of their use, say the authors of a BMJ Online First paper this week.
The Medicines Company announced today that it has received European approval for the use of Angiox® (bivalirudin) as an anticoagulant in patients with heart attacks (so-called ST-segment elevation myocardial infarction (STEMI)) undergoing emergency heart procedures called primary percutaneous coronary intervention (PCI).
› Verified 7 days ago
| NPI Number | 1649591058 |
| Organization Name | ELECTROSTIM MEDICAL SERVICES, INC |
| Doing Business As | EMSI |
| Type | Durable Medical Equipment & Medical Supplies Supplier |
| Address | 2700 W 21st St Ste 4l, Erie, PA 16506 |
| Phone Number | 800-588-8383 |
News Archive
Nurses, just like many of their patients, struggle to find time and motivation to exercise. But a new study may give these all-important caregivers some additional pressure and responsibility: nurses' attitudes can influence whether their patients commit to a healthy lifestyle.
Verastem, Inc., a biopharmaceutical company focused on discovering and developing drugs to treat breast and other cancers by targeting cancer stem cells, announced today that it has raised $32 million through a Series B financing. Proceeds from the financing will support ongoing research and development and will progress drug candidates into clinical development. The first candidate is projected to enter the clinic in 2012.
Three out of five Israeli clinicians report using placebos – inactive treatments or drugs – in treating patients, despite the medical profession's official disapproval of their use, say the authors of a BMJ Online First paper this week.
The Medicines Company announced today that it has received European approval for the use of Angiox® (bivalirudin) as an anticoagulant in patients with heart attacks (so-called ST-segment elevation myocardial infarction (STEMI)) undergoing emergency heart procedures called primary percutaneous coronary intervention (PCI).
› Verified 7 days ago
| NPI Number | 1649598434 |
| Organization Name | ELECTROSTIM MEDICAL SERVICES INC. |
| Doing Business As | EMSI |
| Type | Durable Medical Equipment & Medical Supplies Supplier |
| Address | 9611 Acer Ave Ste 113, El Paso, TX 79925 |
| Phone Number | 800-588-8383 |
News Archive
Nurses, just like many of their patients, struggle to find time and motivation to exercise. But a new study may give these all-important caregivers some additional pressure and responsibility: nurses' attitudes can influence whether their patients commit to a healthy lifestyle.
Verastem, Inc., a biopharmaceutical company focused on discovering and developing drugs to treat breast and other cancers by targeting cancer stem cells, announced today that it has raised $32 million through a Series B financing. Proceeds from the financing will support ongoing research and development and will progress drug candidates into clinical development. The first candidate is projected to enter the clinic in 2012.
Three out of five Israeli clinicians report using placebos – inactive treatments or drugs – in treating patients, despite the medical profession's official disapproval of their use, say the authors of a BMJ Online First paper this week.
The Medicines Company announced today that it has received European approval for the use of Angiox® (bivalirudin) as an anticoagulant in patients with heart attacks (so-called ST-segment elevation myocardial infarction (STEMI)) undergoing emergency heart procedures called primary percutaneous coronary intervention (PCI).
› Verified 7 days ago
| NPI Number | 1710208129 |
| Organization Name | ELECTROSTIM MEDICAL SERVICES, INC |
| Doing Business As | EMSI |
| Type | Durable Medical Equipment & Medical Supplies Supplier |
| Address | 233 12th St, Suite 309, Columbus, GA 31901 |
| Phone Number | 800-588-8383 |
News Archive
Nurses, just like many of their patients, struggle to find time and motivation to exercise. But a new study may give these all-important caregivers some additional pressure and responsibility: nurses' attitudes can influence whether their patients commit to a healthy lifestyle.
Verastem, Inc., a biopharmaceutical company focused on discovering and developing drugs to treat breast and other cancers by targeting cancer stem cells, announced today that it has raised $32 million through a Series B financing. Proceeds from the financing will support ongoing research and development and will progress drug candidates into clinical development. The first candidate is projected to enter the clinic in 2012.
Three out of five Israeli clinicians report using placebos – inactive treatments or drugs – in treating patients, despite the medical profession's official disapproval of their use, say the authors of a BMJ Online First paper this week.
The Medicines Company announced today that it has received European approval for the use of Angiox® (bivalirudin) as an anticoagulant in patients with heart attacks (so-called ST-segment elevation myocardial infarction (STEMI)) undergoing emergency heart procedures called primary percutaneous coronary intervention (PCI).
› Verified 7 days ago
| NPI Number | 1912281288 |
| Organization Name | ELECTROSTIM MEDICAL SERVICES, INC. |
| Doing Business As | EMSI |
| Type | Durable Medical Equipment & Medical Supplies Supplier |
| Address | 6 Parklane Blvd Ste 540, Dearborn, MI 48126 |
| Phone Number | 800-588-8383 |
News Archive
Nurses, just like many of their patients, struggle to find time and motivation to exercise. But a new study may give these all-important caregivers some additional pressure and responsibility: nurses' attitudes can influence whether their patients commit to a healthy lifestyle.
Verastem, Inc., a biopharmaceutical company focused on discovering and developing drugs to treat breast and other cancers by targeting cancer stem cells, announced today that it has raised $32 million through a Series B financing. Proceeds from the financing will support ongoing research and development and will progress drug candidates into clinical development. The first candidate is projected to enter the clinic in 2012.
Three out of five Israeli clinicians report using placebos – inactive treatments or drugs – in treating patients, despite the medical profession's official disapproval of their use, say the authors of a BMJ Online First paper this week.
The Medicines Company announced today that it has received European approval for the use of Angiox® (bivalirudin) as an anticoagulant in patients with heart attacks (so-called ST-segment elevation myocardial infarction (STEMI)) undergoing emergency heart procedures called primary percutaneous coronary intervention (PCI).
› Verified 7 days ago
News Archive
Nurses, just like many of their patients, struggle to find time and motivation to exercise. But a new study may give these all-important caregivers some additional pressure and responsibility: nurses' attitudes can influence whether their patients commit to a healthy lifestyle.
Verastem, Inc., a biopharmaceutical company focused on discovering and developing drugs to treat breast and other cancers by targeting cancer stem cells, announced today that it has raised $32 million through a Series B financing. Proceeds from the financing will support ongoing research and development and will progress drug candidates into clinical development. The first candidate is projected to enter the clinic in 2012.
Three out of five Israeli clinicians report using placebos – inactive treatments or drugs – in treating patients, despite the medical profession's official disapproval of their use, say the authors of a BMJ Online First paper this week.
The Medicines Company announced today that it has received European approval for the use of Angiox® (bivalirudin) as an anticoagulant in patients with heart attacks (so-called ST-segment elevation myocardial infarction (STEMI)) undergoing emergency heart procedures called primary percutaneous coronary intervention (PCI).
› Verified 7 days ago
6th St. Bridge Mobility Type: Durable Medical Equipment & Medical Supplies Supplier Location: 7818 Depot Ln, Tampa, Florida 33637 Phone: (813) 621-2001 | |
A-ability Medical Equipment Inc Type: Durable Medical Equipment & Medical Supplies Supplier Location: 4010 E Hillsborough Ave, Tampa, Florida 33610 Phone: (813) 620-4475 | |
About You Type: Prosthetic/Orthotic Supplier Location: 3401 Henderson Blvd, Tampa, Florida 33609 Phone: (813) 876-2727 | |
Advance Pharmacy Service Llc Type: Pharmacy Location: 4910 N Armenia Ave, Tampa, Florida 33603 Phone: (813) 350-9999 | |
Advocate Medical Services Inc Type: Durable Medical Equipment & Medical Supplies Supplier Location: 5912 Breckenridge Pkwy, Tampa, Florida 33610 Phone: (813) 280-6547 |